Radiation Immuno-Oncology Group, Center for Translational Cancer Research (TranslaTUM), School of medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
Institute of the Russian Academy of Sciences (RAS), 194064 St. Petersburg, Russia.
Cells. 2020 Apr 8;9(4):912. doi: 10.3390/cells9040912.
The major stress-inducible protein Hsp70 (HSPA1A) is overexpressed in the cytosol of many highly aggressive tumor cells including glioblastoma multiforme and presented on their plasma membrane. Depending on its intracellular or membrane localization, Hsp70 either promotes tumor growth or serves as a target for natural killer (NK) cells. The kinetics of the membrane Hsp70 (mHsp70) density on human glioma cells (U87) was studied after different irradiation doses to define the optimal therapeutic window for Hsp70-targeting NK cells. To maintain the cells in the exponential growth phase during a cultivation period of 7 days, different initial cell counts were seeded. Although cytosolic Hsp70 levels remained unchanged on days 4 and 7 after a sublethal irradiation with 2, 4 and 6 Gy, a dose of 2 Gy resulted in an upregulated mHsp70 density in U87 cells which peaked on day 4 and started to decline on day 7. Higher radiation doses (4 Gy, 6 Gy) resulted in an earlier and more rapid onset of the mHsp70 expression on days 2 and 1, respectively, followed by a decline on day 5. Membrane Hsp70 levels were higher on cells in G2/M than in G1; however, an irradiation-induced cell cycle arrest on days 4 and 7 was not associated with an increase in the mHsp70 density. Extracellular Hsp70 concentrations in the supernatant of irradiated cells were significantly higher than sham (0 Gy) irradiated cells on days 4 and 7, but not on day 1. Functionally, elevated mHsp70 densities were associated with a significantly better lysis by Hsp70-targeting NK cells. In summary, the kinetics of changes in the mHsp70 density upon irradiation on tumor cells is time- and dose-dependent.
主要应激诱导蛋白 Hsp70(HSPA1A)在许多高度侵袭性肿瘤细胞的细胞质中过度表达,包括多形性胶质母细胞瘤,并呈现在其质膜上。根据其在细胞内或膜上的定位,Hsp70 要么促进肿瘤生长,要么成为自然杀伤(NK)细胞的靶标。研究了不同辐射剂量后人类神经胶质瘤细胞(U87)膜 Hsp70(mHsp70)密度的动力学,以确定针对 Hsp70 的 NK 细胞治疗的最佳治疗窗口。为了在 7 天的培养期间使细胞保持在指数生长期,接种了不同的初始细胞数。尽管在用 2、4 和 6 Gy 进行亚致死照射后第 4 天和第 7 天细胞质 Hsp70 水平保持不变,但 2 Gy 的剂量导致 U87 细胞中 mHsp70 密度上调,第 4 天达到峰值,第 7 天开始下降。更高的辐射剂量(4 Gy、6 Gy)分别导致 mHsp70 在第 2 天和第 1 天更早更快地开始表达,然后在第 5 天下降。处于 G2/M 期的细胞中膜 Hsp70 水平高于 G1 期;然而,第 4 天和第 7 天的细胞周期阻滞与 mHsp70 密度的增加无关。照射细胞上清液中细胞外 Hsp70 浓度在第 4 天和第 7 天显著高于假照射(0 Gy)细胞,但在第 1 天则不然。功能上,mHsp70 密度的升高与 Hsp70 靶向 NK 细胞的显著更好裂解相关。总之,肿瘤细胞照射后 mHsp70 密度变化的动力学是时间和剂量依赖性的。